Filing Details
- Accession Number:
- 0001831283-23-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-05 16:29:37
- Reporting Period:
- 2023-01-03
- Accepted Time:
- 2023-01-05 16:29:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1831283 | Lianbio | LIAN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1880938 | Jiang Qian | C/O Lianbio, 103 Carnegie Center Drive Suite 309 Princeton NJ 08520 | Svp, China General Manager | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2023-01-03 | 2,239 | $1.65 | 67,349 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale of shares to cover personal income tax obligations upon vesting of restricted share units as required pursuant to the terms of Mr. Qian's restricted share unit award agreement.